Medical Devices

Amid record growth, the supply platform adds top advisors Oliver Gelles and Dr. Anil Idiculla and prepares to launch a new AI invoice verification tool.

A new partnership brings the Aplio i800 EUS to the U.S., offering advanced imaging to improve early, less invasive diagnosis of complex GI conditions.

Medcura adds a Johnson & Johnson heavyweight to its board, aiming to disrupt the surgical hemostasis market with its FDA-designated breakthrough gel, LifeGel.

A new partnership aims to create a continuous data stream from surgery to recovery, using AI to predict and prevent costly gastrointestinal complications.

Diakonos Oncology's personalized therapy, DOC1021, reports impressive survival data in early trials for glioblastoma and pancreatic cancer.

A new gene therapy has helped completely blind patients with Retinitis Pigmentosa regain light perception, offering hope to millions with inherited blindness.

Medtech firm TELA Bio overhauls its board with M&A and turnaround experts, signaling a major strategic shift to accelerate growth and escape losses.

Strata Critical Medical acquires Ohio Valley Perfusion Associates, a strategic move to consolidate the fragmented perfusion market and boost lifesaving care.

Mount Sinai adopts Echo IQ's AI to improve detection of aortic stenosis, a deadly but often-missed heart condition, heralding a new era for cardiac care.

Once a photography giant, Fujifilm's pivot to healthcare and tech has earned it a top spot on TIME's Most Influential list. Here’s the story of its rebirth.

A Colorado clinic is adopting FDA-cleared magnetic pulse technology to treat depression, reflecting a growing demand for non-drug mental health solutions.

A new platform from wealth firm Earned aims to close the critical financial knowledge gap for doctors burdened by debt and complex financial decisions.

A new peer-reviewed study shows Glucotrack's fully implantable glucose monitor is accurate for 240 days, a key step towards a 3-year, no-wearable future.

Medtech titan Brad Saar joins Sonablate's board, signaling a major push to make non-invasive HIFU a global standard for prostate cancer treatment.

A new study shows high success for VVT Med's ScleroSafe varicose vein treatment, but a closer look reveals the need for more long-term data.

New pre-clinical data shows engineered immune cells (iMacrophages) can effectively target and destroy ovarian tumors, offering hope for a new treatment era.

Biotech firm Scribe Therapeutics, co-founded by a Nobel laureate, is pioneering a new gene therapy for high cholesterol that silences genes, not cuts them.

Wellspect HealthCare's new Surity™ catheter targets a growing market, offering a non-invasive solution designed for comfort, discretion, and dignity.

A new imaging agent could slash the years-long diagnostic delay for endometriosis, offering hope to millions of women suffering from the debilitating condition.

Swiss medtech firm CorFlow is tackling a major post-heart attack complication with two pivotal trials, aiming to create a new standard of care.